| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |